NO930244L - Umettede 17beta-substituerte 3-karboksysteroider - Google Patents

Umettede 17beta-substituerte 3-karboksysteroider

Info

Publication number: NO930244L
Authority: NO; Norway
Prior art keywords: group; hydrogen; cycloalkyl; alkyl group; alkyl
Prior art date: 1991-05-24

Application number

NO93930244A

Other languages

English (en)

Norwegian (no)

Other versions

NO930244D0 (no

Inventor

Achille Panzeri

Marcella Nesi

Enrico Di Salle

Original Assignee

Erba Carlo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-24

Filing date

1993-01-25

Publication date

1993-01-27

1993-01-25 Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa

1993-01-25 Publication of NO930244D0 publication Critical patent/NO930244D0/no

1993-01-27 Publication of NO930244L publication Critical patent/NO930244L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Details Of Garments (AREA)
Ceramic Products (AREA)
Dental Preparations (AREA)

NO93930244A 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider NO930244L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ITMI911432A IT1259419B (it)	1991-05-24	1991-05-24	Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
PCT/EP1992/001153 WO1992020700A1 (en)	1991-05-24	1992-05-22	UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS

Publications (2)

Publication Number	Publication Date
NO930244D0 NO930244D0 (no)	1993-01-25
NO930244L true NO930244L (no)	1993-01-27

Family

ID=11359980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO93930244A NO930244L (no)	1991-05-24	1993-01-25	Umettede 17beta-substituerte 3-karboksysteroider

Country Status (26)

Country	Link
US (1)	US5212166A (es)
EP (2)	EP0517047A1 (es)
JP (1)	JP3226919B2 (es)
CN (1)	CN1035055C (es)
AT (1)	ATE155792T1 (es)
AU (1)	AU655280B2 (es)
CA (1)	CA2087953A1 (es)
CZ (1)	CZ281309B6 (es)
DE (1)	DE69221074T2 (es)
DK (1)	DK0540717T3 (es)
ES (1)	ES2106185T3 (es)
FI (1)	FI930277A0 (es)
HU (1)	HUT64083A (es)
ID (1)	ID954B (es)
IE (1)	IE921634A1 (es)
IL (1)	IL101947A (es)
IT (1)	IT1259419B (es)
MX (1)	MX9202438A (es)
MY (1)	MY131089A (es)
NO (1)	NO930244L (es)
NZ (1)	NZ242850A (es)
RU (1)	RU2104283C1 (es)
TW (1)	TW213467B (es)
WO (1)	WO1992020700A1 (es)
YU (1)	YU52992A (es)
ZA (1)	ZA923758B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4291993A (en) *	1992-04-30	1993-11-29	Smithkline Beecham Corporation	17alpha and 17beta -substituted estra-1,3,5(10)-triene-3-carboxylic acid
US5683995A (en) *	1992-11-18	1997-11-04	Smithkline Beecham Corporation	17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) *	1992-11-18	1997-06-24	Smithkline Beecham Corporation	17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
ES2185666T3 (es) *	1993-09-03	2003-05-01	Smithkline Beecham Corp	Formulacion estabilizada para comprimidos.
GB9324371D0 (en) *	1993-11-26	1994-01-12	Erba Carlo Spa	Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) *	1993-12-13	1995-07-04	Eli Lilly And Company	Reduced phenanthrenes
GB9402041D0 (en) *	1994-02-03	1994-03-30	Smithkline Beecham Corp	Compounds
US5714480A (en) *	1994-03-31	1998-02-03	Smithkline Beecham Corporation	Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) *	1994-04-15	1995-10-26	Smithkline Beecham Corporation	17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) *	1994-07-28	1994-09-21	Erba Carlo Spa	3-carboxysteroids with a fluorinated side-chain
US5543417A (en) *	1994-10-21	1996-08-06	Merck & Co., Inc.	Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
US6372712B1 (en)	1998-05-22	2002-04-16	The Board Of Trustees Of The Leland Stanford Jr. University	Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
WO2001021642A1 (de) *	1999-09-22	2001-03-29	Aventis Pharma Deutschland Gmbh	4-benzylaminochinoline konjugaten mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung
EP2671508B1 (en)	2005-04-28	2020-09-16	Proteus Digital Health, Inc.	Pharma-informatics system
US9062126B2 (en)	2005-09-16	2015-06-23	Raptor Pharmaceuticals Inc.	Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
ES2919563T3 (es)	2009-02-20	2022-07-27	Enhanx Biopharm Inc	Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko)	2009-05-06	2018-10-19	라보라토리 스킨 케어, 인크.	활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4377584A (en) *	1978-04-13	1983-03-22	Merck & Co., Inc.	4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4910226A (en) *	1987-04-29	1990-03-20	Smithkline Beckman Corporation	Steroid 5-alpha-reductase inhibitors
US5041433A (en) *	1987-04-29	1991-08-20	Smithkline Beecham Corporation	11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US5032586A (en) *	1989-08-24	1991-07-16	Smithkline Beecham Corporation	7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) *	1990-06-28	1992-02-25	Merck & Co., Inc.	N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
DK0567271T3 (da) *	1992-04-20	1998-02-16	Sankyo Co	Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf

1991
- 1991-05-24 IT ITMI911432A patent/IT1259419B/it active IP Right Grant
1992
- 1992-05-20 YU YU52992A patent/YU52992A/sh unknown
- 1992-05-20 MY MYPI92000863A patent/MY131089A/en unknown
- 1992-05-21 US US07/886,574 patent/US5212166A/en not_active Expired - Lifetime
- 1992-05-21 IL IL10194792A patent/IL101947A/en active IP Right Grant
- 1992-05-21 NZ NZ242850A patent/NZ242850A/en unknown
- 1992-05-22 RU RU93004939A patent/RU2104283C1/ru active
- 1992-05-22 WO PCT/EP1992/001153 patent/WO1992020700A1/en not_active Ceased
- 1992-05-22 TW TW081104019A patent/TW213467B/zh active
- 1992-05-22 MX MX9202438A patent/MX9202438A/es unknown
- 1992-05-22 AU AU17781/92A patent/AU655280B2/en not_active Ceased
- 1992-05-22 CA CA002087953A patent/CA2087953A1/en not_active Abandoned
- 1992-05-22 EP EP92108670A patent/EP0517047A1/en active Pending
- 1992-05-22 CZ CZ93265A patent/CZ281309B6/cs unknown
- 1992-05-22 EP EP92910992A patent/EP0540717B1/en not_active Expired - Lifetime
- 1992-05-22 JP JP50978992A patent/JP3226919B2/ja not_active Expired - Fee Related
- 1992-05-22 HU HU9300176A patent/HUT64083A/hu unknown
- 1992-05-22 ID IDP308292A patent/ID954B/id unknown
- 1992-05-22 AT AT92910992T patent/ATE155792T1/de active
- 1992-05-22 DE DE69221074T patent/DE69221074T2/de not_active Expired - Fee Related
- 1992-05-22 ES ES92910992T patent/ES2106185T3/es not_active Expired - Lifetime
- 1992-05-22 DK DK92910992.4T patent/DK0540717T3/da active
- 1992-05-22 ZA ZA923758A patent/ZA923758B/xx unknown
- 1992-05-23 CN CN92103919A patent/CN1035055C/zh not_active Expired - Fee Related
- 1992-07-01 IE IE163492A patent/IE921634A1/en unknown
1993
- 1993-01-25 NO NO93930244A patent/NO930244L/no unknown
- 1993-05-22 FI FI930277A patent/FI930277A0/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
HU9300176D0 (en)	1993-04-28
CZ281309B6 (cs)	1996-08-14
TW213467B (es)	1993-09-21
MX9202438A (es)	1992-11-01
JPH06500342A (ja)	1994-01-13
NZ242850A (en)	1994-01-26
CZ26593A3 (en)	1993-11-17
AU1778192A (en)	1992-12-30
WO1992020700A1 (en)	1992-11-26
US5212166A (en)	1993-05-18
ZA923758B (en)	1993-01-27
NO930244D0 (no)	1993-01-25
ITMI911432A1 (it)	1992-11-24
ITMI911432A0 (it)	1991-05-24
DE69221074T2 (de)	1997-11-13
IT1259419B (it)	1996-03-18
MY131089A (en)	2007-07-31
DE69221074D1 (de)	1997-09-04
CA2087953A1 (en)	1992-11-25
HUT64083A (en)	1993-11-29
AU655280B2 (en)	1994-12-15
ATE155792T1 (de)	1997-08-15
CN1067057A (zh)	1992-12-16
RU2104283C1 (ru)	1998-02-10
FI930277A7 (fi)	1993-01-22
EP0540717B1 (en)	1997-07-23
ID954B (id)	1996-09-25
IL101947A (en)	1996-01-19
EP0540717A1 (en)	1993-05-12
DK0540717T3 (da)	1997-08-18
FI930277A0 (fi)	1993-01-22
IE921634A1 (en)	1992-12-02
JP3226919B2 (ja)	2001-11-12
EP0517047A1 (en)	1992-12-09
CN1035055C (zh)	1997-06-04
YU52992A (sh)	1995-03-27
ES2106185T3 (es)	1997-11-01

Publication	Publication Date	Title
NO913923L (no)	1991-12-06	17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
NO20091012L (no)	2009-03-26	Kinazolinon- og isokinolinonacetamid derivater
DK0623140T3 (da)	1999-02-15	Nye 19-nor steroider med en svovlcarbonkæde i 11-beta stilling, fremgangsmåde til deres fremstilling og mellemstofferne der
DK117986D0 (da)	1986-03-14	Arylderivater, fremgangsmaader til deres fremstilling og deres anvendelse
NO20071873L (no)	2007-06-15	DNA-PK inhibotorer.
NO20065573L (no)	2007-01-18	Orto-substituerte aryl eller heteroarylamidforbindelser
YU46497B (sh)	1993-10-20	Postupak za dobijanje novih derivata pirazola
RU2005108046A (ru)	2006-02-27	1, 2, 3-триазольные производные, обладающие бактерицидной (например, фунгицидной)активностью
DE69221074D1 (de)	1997-09-04	Ungesatigte 17-beta-substituierte-3-carboxy steroide
TW200503704A (en)	2005-02-01	N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
NO20073787L (no)	2007-09-27	Nye pyrimidin-nukleosidforbindelser eller dets salt
NO951283L (no)	1995-04-03	Nye taxanderivater, deres fremstilling samt farmasöytiske preparater inneholdende derivatene
NO944926L (no)	1995-06-22	Fremgangsmåter for å inhibere myeloperoksidaseaktivitet
NO972951L (no)	1997-12-29	Stabilisatorer for pulverlakker
FI914504A0 (fi)	1991-09-25	Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DE69200284D1 (de)	1994-09-08	Verwendung von 4-(3-trifluormethylphenyl)-1,2,3,6-Tetrahydropyridinderivaten als freie Radikalfänger.
ES2027357T3 (es)	1992-06-01	Una composicion herbicida y su procedimiento de preparacion.
ES468408A1 (es)	1978-12-16	Procedimiento para la preparacion de 1,2,3-tiadiazol-3-in-5-iliden-ureas.
NO951433L (no)	1995-04-12	Kjemiske forbindelser
NO20054053L (no)	2005-10-31	Triazolforbindelser anvendbare i terapi.
ES483214A1 (es)	1980-09-01	Un procedimiento para la preparacion de compuestos derivadosde morfolina y piperidina
NO951072L (no)	1995-09-25	Polyjoderte forbindelser, fremgangsmåte for deres fremstilling og diagnostisk preparat
GB1336263A (en)	1973-11-07	9-substituted erythromycin a and b oximes
ATE316953T1 (de)	2006-02-15	Stabilisator für hydroxylaminlösungen
TR199900768T2 (xx)	1999-08-23	Hidroksimik ve hidrazonik gruplu fungisidler.